Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PNMT | P11086 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258606 | 0.97 | — | — | |
| SCHEMBL29152755 | 0.94 | TSHR (0.46) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| Hydrochloric Acid SCHEMBL22230526 | 0.94 | TSHR (0.46) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL29126143 | 0.94 | TSHR (0.46) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL828884 | 0.90 | TSHR (0.42) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL10489573 | 0.76 | TSHR (0.55) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL23239 | 0.75 | — | — | |
| SCHEMBL3991309 | 0.75 | TSHR (0.61) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL6675833 | 0.73 | CYP3A4 (0.48) | TSHRPNMTCYP1A2CYP2A6LMNA | |
| SCHEMBL970761 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102574989-B | Polymer purification method and polymer | MITSUI CHEMICALS INC | 2014-03-26 | — | — | CN | disclosed |
| CN-102574989-A | Polymer purification method and polymer | MITSUI CHEMICALS INC | 2012-07-11 | — | — | CN | disclosed |
| CN-101291944-B | Process for producing organic transition metal complex compound, metathesis catalyst produced by the process, metathesis polymer formed by ring opening polymerization with the same, and process for pr | MITSU CHEMICALS INC | 2012-07-04 | — | — | CN | disclosed |
| CN-101490126-B | Ring-opening metathesis polymer, hydrogenated product thereof, process for producing the same, and use thereof | MITSUI CHEMICALS INC | 2011-09-14 | — | — | CN | disclosed |
| CN-101490126-A | Ring-opening metathesis polymer, hydrogenated product thereof, process for producing the same, and use thereof | MITSUI CHEMICALS INC (JP) | 2009-07-22 | — | — | CN | disclosed |
| US-20090124772-A1 | PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER | MITSUI CHEMICALS, INC. (JP) | 2009-05-14 | — | — | US | disclosed |
| CN-101291944-A | Process for producing organic transition metal complex compound, metathesis catalyst produced by the process, metathesis polymer formed by ring opening polymerization with the same, and process for pr | MITSUI CHEMICALS INC (JP) | 2008-10-22 | — | — | CN | disclosed |
| EP-1950216-A1 | PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY THE PROCESS, METATHESIS POLYMER FORMED BY RING OPENING POLYMERIZATION WITH THE SAME, AND PROCESS FOR PRODUCING POLYMER WITH THE SAME | Mitsui Chemicals, Inc. (JP) | 2008-07-30 | — | — | EP | disclosed |
| CN-1249119-C | Hydrogenated ring-opening metathesis copolymer and process for producing the same | MITSUI CHEMICALS INC (JP) | 2006-04-05 | — | — | CN | disclosed |
| CN-1233685-C | Fluorinated cycloolefin polymer, cycloolefin monomer thereof, preparation method of polymer and application of polymer | MITSUI CHEMICALS INC (JP) | 2005-12-28 | — | — | CN | disclosed |
| CN-1462286-A | Fluorinated cycloolefin polymers, its cycloolefin monomers processes for preparation of polymers thereof and use of the same | MITSUI CHEMICALS INC (JP) | 2003-12-17 | — | — | CN | disclosed |
| CN-1380888-A | Hydrogenated ring-opening metathesis polymer and process for producing the same | MITSUI CHEMICALS INC (JP) | 2002-11-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124772-A1 | PROCESS FOR PRODUCING ORGANIC TRANSITION METAL COMPLEX COMPOUND, METATHESIS CATALYST PRODUCED BY USING THE SAME, RING-OPENING METATHESIS POLYMER OBTAINABLE WITH THE METATHESIS CATALYST, AND PROCESS FOR PRODUCING THE POLYMER | PORCN, ICMT, ME1 | TSHR 4344/4885PNMT 210/4885CYP1A2 2537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.